Mitochondrial ATP Synthase in Cardiac Biology and Disease
线粒体 ATP 合酶在心脏生物学和疾病中的作用
基本信息
- 批准号:10758687
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:ATP Synthesis PathwayAccelerationAcuteAddressAdrenergic AgentsAdultBiologyCardiacCardiac MyocytesCellsComplementDeteriorationDiseaseEFRACEchocardiographyExerciseFundingGene DeletionGenerationsGoalsHealthHeart failureHuman ResourcesHyperthyroidismIsoproterenolKnock-outKnockout MiceMammalian CellMediatingMitochondriaMitochondrial Proton-Translocating ATPasesModelingMusPathologicPathway interactionsPerformancePhenotypePhysiologicalPregnancyProtocols documentationRestRunningStimulusStressWild Type MouseWorkcardiac pacingchronotropicconditioningheart functionmouse modelparent grantpharmacologicphysiologic stressorpressureresponsetreadmill
项目摘要
We have created two independent mouse models of adult cardiomyocyte-specific mitochondrial ATP synthase
deficiency: cardiomyocyte-specific ATP5L knockout (KO) mice and cardiomyocyte-specific ATP5J KO mice.
Analysis of both models have shown that mice with ~90% depletion of the mitochondrial ATP synthase
unexpectedly remain healthy with normal cardiac function for several weeks before transitioning to lethal heart
failure with reduced ejection fraction (HFrEF). Studies in the parent grant are investigating the compensatory
mechanisms that maintain cardiac function in the face of severe mitochondrial ATP synthase depletion in
cardiomyocytes and the mechanisms that eventually mediate the transition to heart failure which, interestingly,
do not appear to involve further deterioration of cardiac energetics. Given the traditional view that the
mitochondrial ATP synthesis is essential to sustain energetics in mammalian cells – especially energy-
demanding cells such as cardiomyocytes – it is surprising that ~10% of its usual levels in cardiomyocytes are
adequate to sustain basal mouse health and cardiac function. Our results suggest that the full complement of
mitochondrial ATP synthase in cardiomyocytes is not needed at rest. This observation raises the question as to
how much of the mitochondrial ATP synthase is needed in cardiomyocytes to sustain cardiac function under
more energetically demanding conditions, a question that could not be previously addressed without these
mouse models. To answer this question, it is necessary to impose a physiological stress on the mice that
increases the energetic demands of cardiomyocytes – but without simultaneously activating pathological stress
pathways. We have chosen to use acute β-adrenergic stimulation with isoproterenol and, independently, acute
exercise. A second objective of the Supplement is to deepen our baseline characterization of the ATP5J KO
mice, which were generated by the candidate. The baseline characterization of the ATP5L KO mice is already
complete. However, studies performed after the parent grant was funded, show that the ATP5J KO mice appear
to have an accelerated phenotype. Hence, these mice need a thorough baseline characterization. Thus, the
specific aims are: 1. To extend the baseline characterization of the cardiomyocyte-specific ATP5J knockout mice.
2. To assess the response of cardiomyocyte-specific ATP5L KO and ATP5J KO mouse lines to physiological
stimuli that increase cardiomyocyte energetic demands. The scientific questions addressed in this Supplement
are directly related to those of the parent grant and the resulting information will enhance our understanding of
the findings of the parent grant. However, both the proposed work in the Supplement and the personnel required
to perform it are distinct from that in the parent grant.
我们创建了两种独立的成年心肌细胞特异性线粒体 ATP 合酶小鼠模型
缺陷:心肌细胞特异性 ATP5L 敲除(KO)小鼠和心肌细胞特异性 ATP5J KO 小鼠。
对两种模型的分析表明,线粒体 ATP 合酶耗竭约 90% 的小鼠
在转变为致命的心脏之前,意外地在数周内保持健康和正常的心脏功能
射血分数降低(HFrEF)的失败。母基金的研究正在调查代偿性。
线粒体 ATP 合酶严重耗竭时维持心脏功能的机制
心肌细胞和最终介导向心力衰竭转变的机制,有趣的是,
鉴于传统观点认为,这似乎并不涉及心脏能量的进一步恶化。
线粒体 ATP 合成对于维持哺乳动物细胞的能量(尤其是能量)至关重要
心肌细胞等要求较高的细胞——令人惊讶的是,心肌细胞中约 10% 的正常水平
足以维持小鼠的基础健康和心脏功能。我们的结果表明,充分补充
心肌细胞在休息时不需要线粒体 ATP 合酶。这一观察结果提出了一个问题:
心肌细胞需要多少线粒体 ATP 合酶来维持心脏功能
更加严格的条件,如果没有这些条件,以前就无法解决这个问题
为了回答这个问题,有必要对小鼠施加生理应激,
增加心肌细胞的能量需求——但不会同时激活病理应激
我们选择使用异丙肾上腺素进行急性β-肾上腺素刺激,并且独立地进行急性刺激。
补充的第二个目标是加深我们对 ATP5J KO 的基线表征。
候选小鼠产生的 ATP5L KO 小鼠的基线特征已经确定。
然而,在获得父母资助后进行的研究表明,ATP5J KO 小鼠出现了。
因此,这些小鼠需要彻底的基线表征。
具体目标是: 1. 扩展心肌细胞特异性 ATP5J 敲除小鼠的基线特征。
2. 评估心肌细胞特异性 ATP5L KO 和 ATP5J KO 小鼠系对生理系的反应
增加心肌细胞能量需求的刺激本补充材料中解决的科学问题。
与母公司补助金直接相关,由此产生的信息将增强我们对
然而,补编中拟议的工作和所需的人员。
执行它与父补助金中的执行不同。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard N Kitsis其他文献
Richard N Kitsis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard N Kitsis', 18)}}的其他基金
Mitochondrial ATP Synthase in Cardiac Biology and Disease
线粒体 ATP 合酶在心脏生物学和疾病中的作用
- 批准号:
10632143 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Caspase-9 as a nodal point connecting necrotic and apoptotic cell death in myocardial infarction
Caspase-9作为连接心肌梗死细胞坏死和凋亡的节点
- 批准号:
10666668 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Caspase-9 as a nodal point connecting necrotic and apoptotic cell death in myocardial infarction
Caspase-9 作为连接心肌梗死细胞坏死和凋亡的节点
- 批准号:
10504387 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Mitochondrial ATP Synthase in Cardiac Biology and Disease
线粒体 ATP 合酶在心脏生物学和疾病中的作用
- 批准号:
10812556 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Mitochondrial ATP Synthase in Cardiac Biology and Disease
线粒体 ATP 合酶在心脏生物学和疾病中的作用
- 批准号:
10446745 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Modulation of Mitofusin Activity to Treat Heart Disease
调节丝裂霉素活性治疗心脏病
- 批准号:
10280485 - 财政年份:2021
- 资助金额:
$ 2.05万 - 项目类别:
Modulation of Mitofusin Activity to Treat Heart Disease
调节丝裂霉素活性治疗心脏病
- 批准号:
10458699 - 财政年份:2021
- 资助金额:
$ 2.05万 - 项目类别:
Modulation of Mitofusin Activity to Treat Heart Disease
调节丝裂霉素活性治疗心脏病
- 批准号:
10655447 - 财政年份:2021
- 资助金额:
$ 2.05万 - 项目类别:
相似国自然基金
高功率激光驱动低β磁重联中磁岛对电子加速影响的研究
- 批准号:12305275
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
U型离散顺流火蔓延非稳态热输运机理与加速机制研究
- 批准号:52308532
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NOTCH3/HLF信号轴驱动平滑肌细胞表型转化加速半月板退变的机制研究
- 批准号:82372435
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
TWIST1介导的ITGBL1+肿瘤相关成纤维细胞转化加速结肠癌动态演化进程机制及其预防干预研究
- 批准号:82373112
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
实施科学视角下食管癌加速康复外科证据转化障碍机制与多元靶向干预策略研究
- 批准号:82303925
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The Role of Dopamine in Cognitive Resilience to Alzheimer's Disease Pathology in Healthy Older Adults
多巴胺在健康老年人阿尔茨海默氏病病理认知弹性中的作用
- 批准号:
10678125 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
- 批准号:
10678789 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
- 批准号:
10679628 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Feasibility of Using PET Imaging for Detection of Treatment-Induced Changes in Chronic Neuroinflammation Following TBI
使用 PET 成像检测 TBI 后治疗引起的慢性神经炎症变化的可行性
- 批准号:
10703823 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Energizing and Protecting Axons Through Metabolic Coupling to Schwann Cells
通过与雪旺细胞的代谢耦合来激活和保护轴突
- 批准号:
10647707 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别: